Serological assessment of neutrophil elastase activity on elastin during lung ECM remodeling

Jacob Hull Kristensen, Morten A. Karsdal, Jannie M. B. Sand, Nicholas Willumsen, Claudia Diefenbach, Birte Svensson, Per Hägglund, Diana J. Oersnes-Leeming

    Research output: Contribution to journalJournal articleResearchpeer-review

    445 Downloads (Pure)

    Abstract

    Background: During the pathological destruction of lung tissue, neutrophil elastase (NE) degrades elastin, one of the major constituents of lung parenchyma. However there are no non-invasive methods to quantify NE degradation of elastin. We selected specific elastin fragments generated by NE for antibody generation and developed an ELISA assay (EL-NE) for the quantification of NE-degraded elastin. 
    Methods: Monoclonal antibodies were developed against 10 NE-specific cleavage sites on elastin. One EL-NE assay was tested for analyte stability, linearity and intra-and inter-assay variation. The NE specificity was demonstrated using elastin cleaved in vitro with matrix metalloproteinases (MMPs), cathepsin G (CatG), NE and intact elastin. Clinical relevance was assessed by measuring levels of NE-generated elastin fragments in serum of patients diagnosed with idiopathic pulmonary fibrosis (IPF, n = 10) or lung cancer (n = 40). 
    Results: Analyte recovery of EL-NE for human serum was between 85% and 104%, the analyte was stable for four freeze/thaw cycles and after 24 h storage at 4 degrees C. EL-NE was specific for NE-degraded elastin. Levels of NE-generated elastin fragments for elastin incubated in the presence of NE were 900% to 4700% higher than those seen with CatG or MMP incubation or in intact elastin. Serum levels of NE-generated elastin fragments were significantly increased in patients with IPF (137%, p = 0.002) and in patients with lung cancer (510%, p <0.001) compared with age-and sex-matched controls. 
    Conclusions: The EL-NE assay was specific for NE-degraded elastin. The EL-NE assay was able to specifically quantify NE-degraded elastin in serum. Serum levels of NE-degraded elastin might be used to detect excessive lung tissue degradation in lung cancer and IPF.
    Original languageEnglish
    JournalBMC Pulmonary Medicine
    Volume15
    Issue number53
    Number of pages7
    ISSN1471-2466
    DOIs
    Publication statusPublished - 2015

    Bibliographical note

    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

    Keywords

    • Respiratory
    • Idiopathic pulmonary-fibrosis
    • Cancer
    • Degradation
    • Biomarker
    • Neutrophil elastase
    • IPF
    • ECM
    • Lung cancer
    • Elastin

    Fingerprint

    Dive into the research topics of 'Serological assessment of neutrophil elastase activity on elastin during lung ECM remodeling'. Together they form a unique fingerprint.

    Cite this